Search

#ObesityTreatment

NASDAQ Stock Market @nasdaq.com · New York City 🇺🇸 · Mar 20

#Wegovy #NovoNordisk #ObesityTreatment

FDA Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients

Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7. 2 mg) to reduce excess body weight and maintain weight reduction in the long term.

U.S. News & World Report @usnews.com · Washington (state) 🇺🇸 · Mar 19

#Wegovy #ObesityTreatment #FDAApproval

FDA Approves New Higher-Dose Version of Wegovy Shots

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off.

Barchart.com @barchart.com · United States 🇺🇸 · Mar 19

#Wegovy #ObesityTreatment #FDAApproval

www.barchart.com

FDA approves new higher-dose version of Wegovy shots

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off.

San Francisco Gate @sfgate.com · San Francisco 🇺🇸 · Mar 19

#Wegovy #ObesityTreatment #FDAApproval

FDA approves new higher-dose version of Wegovy shots

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off.

CNBC @cnbc.com · New Jersey 🇺🇸 · Feb 6

#Pfizer #ObesityTreatment #HealthcareInnovation

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal's Future of Everything Festival in New York City, U.

U.S. News & World Report @usnews.com · Washington (state) 🇺🇸 · Jan 22

#GLP1 #ObesityTreatment #DiabetesManagement

GLP-1 Medications: A Comprehensive Overview

CBS News @cbsnews.com · New York 🇺🇸 · Jan 5

#WeightLoss #HealthInnovation #ObesityTreatment

www.cbsnews.com

Novo Nordisk debuts Wegovy weight-loss pill in the U.S.

Mary Cunningham is a reporter for CBS MoneyWatch.

Daily Voice @dailyvoice.com · Jan 5

#ObesityTreatment #GLP1 #WeightLossMedication

First GLP-1 Weight-Loss Pill Hits Pharmacies: How Much It Costs, What To Know

The first oral glucagon-like peptide-1 (GLP-1) drug has launched nationwide, marking a major expansion of access to the popular treatments credited with reshaping obesity care in the US.

Daily Voice @dailyvoice.com · Jan 5

#ObesityTreatment #GLP1 #WeightLossMedication

First GLP-1 Weight-Loss Pill Hits Pharmacies: How Much It Costs, What To Know

The first oral glucagon-like peptide-1 (GLP-1) drug has launched nationwide, marking a major expansion of access to the popular treatments credited with reshaping obesity care in the US.

Daily Voice @dailyvoice.com · Jan 5

#GLP1 #ObesityTreatment #WeightLoss

First GLP-1 Weight-Loss Pill Hits Pharmacies: How Much It Costs, What To Know

The first oral glucagon-like peptide-1 (GLP-1) drug has launched nationwide, marking a major expansion of access to the popular treatments credited with reshaping obesity care in the US.

Daily Voice @dailyvoice.com · Jan 5

#GLP1 #ObesityTreatment #WeightManagement

NJ Drugmaker's First GLP-1 Weight-Loss Pill Hits Pharmacies: What To Know

The first oral glucagon-like peptide-1 (GLP-1) drug has launched nationwide, marking a major expansion of access to the popular treatments credited with reshaping obesity care in the US.

Daily Voice @dailyvoice.com · Jan 5

#GLP1 #WeightLoss #ObesityTreatments

NJ Drugmaker's First GLP-1 Weight-Loss Pill Hits Pharmacies: What To Know

The first oral glucagon-like peptide-1 (GLP-1) drug has launched nationwide, marking a major expansion of access to the popular treatments credited with reshaping obesity care in the US.

Daily Voice @dailyvoice.com · Jan 5

#GLP1 #ObesityTreatment #WeightLoss

NJ Drugmaker's First GLP-1 Weight-Loss Pill Hits Pharmacies: What To Know

The first oral glucagon-like peptide-1 (GLP-1) drug has launched nationwide, marking a major expansion of access to the popular treatments credited with reshaping obesity care in the US.

Daily Voice @dailyvoice.com · Jan 5

#WeightManagement #ObesityTreatment #GLP1Pills

First GLP-1 Weight-Loss Pill Hits Pharmacies: How Much It Costs, What To Know

The first oral glucagon-like peptide-1 (GLP-1) drug has launched nationwide, marking a major expansion of access to the popular treatments credited with reshaping obesity care in the US.

NASDAQ Stock Market @nasdaq.com · New York City 🇺🇸 · Jan 5

#WeightManagement #ObesityTreatment #PharmaceuticalInnovation

Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026?

Last month, Novo Nordisk NVO announced the FDA approval of the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular (CV) events.

Benzinga @benzinga.com · Detroit 🇺🇸 · Jan 5

#ObesityTreatment #ClinicalTrials #MetabolicHealth

ScienceDaily @sciencedaily.com · Jan 4

#ObesityTreatment #HealthInequality #NHSAccess

www.sciencedaily.com

Breakthrough obesity drugs are here but not for everyone

Access to obesity treatment in the UK may be heading toward a two-tier system, raising concerns that some of the most vulnerable patients could be left without help.